Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hutchmed China Ltd (13 HK)
Watchlist
166
Analysis
Industrials
•
Hong Kong
HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hutchmed China Ltd
•
12 Mar 2024 08:55
Hutchmed China Ltd (13.HK/HCM.US) - High Growth Is Expected from 2024 to 2026
HUTCHMED will enter a period of accelerated growth in product revenue based on major catalysts in 2024 to 2026. Global sales of fruquintinib will...
Xinyao (Criss) Wang
Follow
337 Views
Share
bullish
•
Hutchmed China Ltd
•
01 Mar 2024 19:54
•
Broker
Hutchmed (13 HK) – A Fruitful 2024 on the Way
Including US$312mn upfront and milestone payments from Takeda, HCM’s consolidated revenues from oncology/immunology reached US$529mn in FY23
CMB International
Follow
331 Views
Share
bullish
•
Hutchmed China Ltd
•
20 Feb 2024 08:55
Hutchmed China Ltd (13.HK/HCM.US) - 2023 Results Preview and Catalysts in 2024
HUTCHMED has entered a harvest period.Product revenue would grow rapidly in the next two years, with promising catalysts head.Together with...
Xinyao (Criss) Wang
Follow
300 Views
Share
bullish
•
Hutchmed China Ltd
•
20 Dec 2023 08:55
Hutchmed China Ltd (13.HK/HCM.US) - A Valuable Option in the Portfolio
Despite market's lackluster response to fruquintinib’s FDA approval, we're optimistic about HUTCHMED’s outlook.Rich cash flow/future catalysts make...
Xinyao (Criss) Wang
Follow
428 Views
Share
bullish
•
Hutchmed China Ltd
•
10 Nov 2023 19:31
•
Broker
Hutchmed (13 HK) – Big Milestone Achieved with Fruquintinib Successfully Approved by US FDA
The approval was based on the Ph3 MRCT FRESCO-2 (18% patients enrolled from the US) as well as the China FRESCO trial, implying the recognition of...
CMB International
Follow
372 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.28.3
x